(Date:11/19/2009)...any countries of the world. It is widely used for ...erials. It also is considered an exemplar plant sp...ion, and genome architecture. The authors of the r...the first description of the B73 maize genome to p...tics and plant biology. The ten papers consider ma...
(Date:11/19/2009)...diversity in maize, also known as corn, researcher...map that should pave the way to significant improv...fuel, animal feed and fiber around the world. , ... haplotype map, charts genetic diversity and recom...aize. The research team, led by U.S. Department of...
(Date:11/19/2009)... -- Sustainable farming, initially adopted to pres... play a role in maintaining a healthy climate, acc...s Oak Ridge and Los Alamos national laboratories. ...ge potential of the earth,s soils to sequester car...ctices could greatly reduce U.S. carbon emissions ...
Breaking Biology News(10 mins):PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3AMA Inaugurates J James Rohack as President 49139 1AMA Inaugurates J James Rohack as President 49139 2VIDEO from Medialink and Siemens 3A New Treatment in Breast Cancer Detection 49138 1Nanobiotech Center Wins 242 5 Million 4 Year Grant 12659 1Nanobiotech Center Wins 242 5 Million 4 Year Grant 12659 2Nanobiotech Center Wins 242 5 Million 4 Year Grant 12659 3(Date:11/20/2009)... METTLER TOLEDO recently a...a free webinar, “The Role of Process Analyti...Engineering” on December 1, 2009. , ...ng the The Role of Process Analytical Technology ...inar on December 1, Process Analytical Technology...
(Date:11/19/2009)..., , ,, BETHESDA, Md., Nov. 19 /PRNe... SPEX ), an innovator in biotechnology for diabet...tory consulting services to food, supplement, biot...today it closed the previously reported $6.3 milli...vestors of 2,760,870 shares of its common stock an...
(Date:11/19/2009)..., , MONTREAL, Nov. 19 /PRNewswire/ - Aegera ...e first patient in a randomized Phase 2B study of ...stage development for multiple oncology indication...ized Phase 2 Study of the X-Linked Inhibitor of Ap...tion with High-dose Cytarabine and Idarubicin in A...
(Date:11/18/2009)..., , DAVIS, Calif., Nov. 18 Ma...very, development and commercialization of effecti... products, announced that it has been named an IC2...tes, oldest and largest national angel investing g...erformance leading to rewarding results for all st...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Marrone Bio Innovations Named an IC20 Company 2...oved Second Quarter Product Revenue and Continues ..., WAYNE, Pa., Feb. 14 Escalon Medical Corp.,(Nas...l second quarter and,six months ended December 31,...e Company reported improved,sales in the Company,s...),business units, which increased approximately 16...
...enue Increased 69.8% to $7.7 million ...Second Quarter Net Income Increased 67.5% to $1.7 ... to $14.9 million and Net Income Increas...owth Driven by New Distribution Partners and Incre...ducts, CHENGDU, China, Feb. 14 /Xinhua-PRNewswire...
...February 14 Executives from Senexis,and O2H, both...under which,O2H will provide synthetic and computa...ogrammes at Senexis on an FTE basis., "We believe...ntary,expertise of both organisations and will ben...ng-related diseases by helping Senexis increase,th...
Other Biology Technology:Escalon(R) Reports Second Quarter Fiscal 2008 Results 2Escalon(R) Reports Second Quarter Fiscal 2008 Results 3Escalon(R) Reports Second Quarter Fiscal 2008 Results 4Escalon(R) Reports Second Quarter Fiscal 2008 Results 5Escalon(R) Reports Second Quarter Fiscal 2008 Results 6Escalon(R) Reports Second Quarter Fiscal 2008 Results 7Escalon(R) Reports Second Quarter Fiscal 2008 Results 8Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results 2Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results 3Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results 4Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results 5Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results 6Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results 7Tianyin Pharmaceutical Co., Inc. Announces Second Quarter 2008 Financial Results 8Senexis and O2H (Oxygen Healthcare) Announce Medicinal Chemistry Collaboration 2Rabbit Anti-Human ALPHA-2-ANTIPLASMIN Polyclonal Antibody, Unconjugated from AbD Serotec
...prime Plus DNA Polymerase with a proprietary therm...higher fidelity than standard Taq DNA polymerase, ...Amplifies DNA templates >20kb, Concentration: 5U/u...for cloning and mutagenesis We are part of Thermo ...
... (E-22013) provides,researchers with a sensitive a...ution. This fluorescence-based assay can detect,ly...say,measures lysozyme activity on Micrococcus lyso...degree that the fluorescence,is quenched. Lysozyme...
...y assay based on measurenment of enzyme activity o...crotiter plate. The procedure includes two incubat...d enzyme reaction) separated by a washing step. T...n enzymaticaly active TRAP 5 (Tartrate Resistant A...
Biology Products: